Daniel MacLachlan - 09 Nov 2026 Form 4 Insider Report for Red Violet, Inc. (RDVT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Nov 2026, 17:59:55 UTC
Prior SEC filing
01 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Daniel MacLachlan
Filing notes and source

Key filing fact

Daniel MacLachlan filed Form 4 for Red Violet, Inc. (RDVT) on 12 Nov 2026.

Key facts

  • This page summarizes Daniel MacLachlan's Form 4 filing for Red Violet, Inc. (RDVT).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Nov 2026, 17:59.

Change

  • Previous filing in this sequence was filed on 01 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001640723 Primary reporting owner

MacLachlan Daniel

Relationship
Chief Financial Officer
Address
C/O RED VIOLET, INC., 2650 N. MILITARY TRAIL, SUITE 300, BOCA RATON
Signature
/s/ Daniel MacLachlan
Signature date
12 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RDVT transaction

Common Stock

Tax liability

Transaction value
Shares
-4,132
Change %
-1.2%
Price
$70.10*
Shares after
354,304
Date
09 Nov 2026
Ownership
Direct
Footnotes
F1, F2, F3, F4
RDVT transaction

Common Stock

Gift

Transaction value
Shares
-1,500
Change %
-0.42%
Price
Shares after
352,804
Date
10 Nov 2026
Ownership
Direct
Footnotes
F2, F3, F4, F5
RDVT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
466
Date
09 Nov 2026
Ownership
Held by IRA
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents the disposition to issuer for tax obligations upon the vesting of the second tranche of 10,500 Restricted Stock Units (RSUs) of the grant originally approved by the Company's Compensation Committee on November 4, 2024.

Footnote F2

Includes 13,333 RSUs originally granted on November 30, 2023, convertible into common stock of the issuer on a one-for-one basis, which vests on December 1, 2026, subject to accelerated vesting under certain circumstances.

Footnote F3

Includes 10,500 RSUs originally granted on November 4, 2024, convertible into common stock of the issuer on a one-for-one basis, which vests on November 1, 2027, subject to accelerated vesting under certain circumstances.

Footnote F4

Includes 18,520 RSUs originally granted December 19, 2025 convertible into common stock of the issuer on a one-for-one basis, which vests in three equal installments on each of December 1, 2026, December 1, 2027, and December 1, 2028, subject to accelerated vesting under certain circumstances.

Footnote F5

This transaction represented a gift/charitable donation effective November 10, 2026, to a qualified religious and educational organization. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .